Embattled Researchers See Path Forward for Anti-CD47 Cancer Drugs
With recent high-profile failures, experts say safety concerns and a lack of diversification are hindering the field—but still hold out hope for an approval.
Embattled Researchers See Path Forward for Anti-CD47 Cancer Drugs Read More »
